Cresset Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $192K | Buy |
|
|||||
|
2025
Q2 | $123K | Sell |
|
|||||
|
2025
Q1 | $132K | Sell |
|
|||||
|
2024
Q4 | $169K | Sell |
|
|||||
|
2024
Q3 | $466K | Sell |
|
|||||
|
2024
Q2 | $550K | Buy |
|
|||||
|
2024
Q1 | $634K | Buy |
|
|||||
|
2023
Q4 | $514K | Buy |
|
|||||
|
2023
Q3 | $115K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $361K | Hold |
|
|||||
|
2022
Q3 | $499K | Hold |
|
|||||
|
2022
Q2 | $381K | Sell |
|
|||||
|
2022
Q1 | $337K | Sell |
|
|||||
|
2021
Q4 | $2.29M | Buy |
|